J3055 Injection, talquetamab-tgvs, 0.25 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj talquetamab-tgvs 0.25 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, talquetamab-tgvs, 0.25 mg | yes |
Related codes in J30
- J3000 Injection, streptomycin, up to 1 gm
- J3010 Injection, fentanyl citrate, 0.1 mg
- J3030 Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J3031 Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3032 Injection, eptinezumab-jjmr, 1 mg
- J3060 Injection, taliglucerase alfa, 10 units
- J3070 Injection, pentazocine, 30 mg
- J3090 Injection, tedizolid phosphate, 1 mg
- J3095 Injection, telavancin, 10 mg